ロード中...
Role of combining neutrophil-to-lymphocyte ratio and pretreatment body mass index in predicting progression-free survival in patients with non-small cell lung cancer treated with nivolumab
Identifying markers capable of predicting outcomes in lung cancer patients treated with nivolumab represents a growing research interest. The combination of neutrophil-to-lymphocyte ratio (NLR) and body mass index (BMI) may help predict treatment efficacy. Thus, the present study aimed to investigat...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8014982/ https://ncbi.nlm.nih.gov/pubmed/33815599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9958 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|